1. Home
  2. MLYS
  3. MLYS News

Latest Mineralys Therapeutics Inc. (MLYS) News on April 19, 2025

Institutional investors must be pleased after a 8.1% gain last week that adds to Mineralys Therapeutics, Inc.'s (NASDAQ:MLYS) one-year returns
MLYS

Simply Wall St.

7 days ago

Institutional investors must be pleased after a 8.1% gain last week that adds to Mineralys Therapeutics, Inc.'s (NASDAQ:MLYS) one-year returns

MLYS

MT Newswires

16 days ago

Mineralys Therapeutics Insider Sold Shares Worth $879,008, According to a Recent SEC Filing

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)
MLYS

GlobeNewswire

21 days ago

Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25)

Mineralys Therapeutics, Inc. (MLYS): Among Stocks Receiving the Most Insider Love in March
MLYS

Insider Monkey

25 days ago

Mineralys Therapeutics, Inc. (MLYS): Among Stocks Receiving the Most Insider Love in March

Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET
MLYS

GlobeNewswire

25 days ago

Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET

Is Mineralys Therapeutics, Inc. (MLYS) a Pump and Dump Stock Favored by Hedge Funds?
MLYS

Insider Monkey

a month ago

Is Mineralys Therapeutics, Inc. (MLYS) a Pump and Dump Stock Favored by Hedge Funds?

Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock

MLYS

MT Newswires

a month ago

Mineralys Therapeutics Insider Bought Shares Worth $8,100,000, According to a Recent SEC Filing

Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics Announces Data from the Phase 2 Advance-HTN Trial of Lorundrosat for the Treatment of Hypertension Has Been Accepted as a Late-Breaking Presentation at the 2025 American College of Cardiology’s Annual Scientific Session & Expo

MLYS

MT Newswires

a month ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

MLYS

MT Newswires

a month ago

Mineralys Therapeutics Prices $175 Million Share Offering

Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock

MLYS

MT Newswires

a month ago

Mineralys Therapeutics Launches $250 Million Public Offering of Shares

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

MLYS

MT Newswires

a month ago

Sector Update: Health Care Stocks Decline Late Afternoon

MLYS

MT Newswires

a month ago

Top Midday Gainers

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate
MLYS

Benzinga

a month ago

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Mineralys’s stock soars as hypertension pill scores in two pivotal trials
MLYS

Clinical Trials Arena

a month ago

Mineralys’s stock soars as hypertension pill scores in two pivotal trials

MLYS

MT Newswires

a month ago

Mineralys Therapeutics Says Lorundrostat Met Trial Endpoints for Treating Hypertension; Shares Up Pre-Bell

Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension

Mineralys Therapeutics to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET
MLYS

GlobeNewswire

a month ago

Mineralys Therapeutics to Announce Topline Data from Launch-HTN and Advance-HTN Pivotal Trials Monday, March 10, 2025, at 8:00 AM ET

MLYS

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Mineralys Therapeutics Inc Earnings Call

MLYS

GuruFocus.com

2 months ago

Mineralys Therapeutics Inc (MLYS) Q4 2024 Earnings Call Highlights: Navigating Increased ...

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
MLYS

GlobeNewswire

2 months ago

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025
MLYS

GlobeNewswire

2 months ago

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025

MLYS

MT Newswires

2 months ago

Mineralys Completes Enrollment in Mid-Stage Hypertension Trial

Mineralys Therapeutics Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and Albuminuria
MLYS

GlobeNewswire

2 months ago

Mineralys Therapeutics Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and Albuminuria

Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials
MLYS

TipRanks

3 months ago

Mineralys Therapeutics Advances Lorundrostat to Phase 2 Trials

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
MLYS

GlobeNewswire

3 months ago

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension

Mineralys Therapeutics Announces Q3 2024 Results and Updates
MLYS

TipRanks

5 months ago

Mineralys Therapeutics Announces Q3 2024 Results and Updates

MLYS

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Mineralys Therapeutics Inc Earnings Call

MLYS

MT Newswires

5 months ago

Mineralys Therapeutics Q3 Net Loss Widens

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
MLYS

GlobeNewswire

5 months ago

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Participate in Upcoming Investor Conferences
MLYS

GlobeNewswire

5 months ago

Mineralys Therapeutics to Participate in Upcoming Investor Conferences

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024
MLYS

GlobeNewswire

5 months ago

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
MLYS

GlobeNewswire

6 months ago

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024
MLYS

GlobeNewswire

6 months ago

Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024

We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate
MLYS

Simply Wall St.

6 months ago

We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension
MLYS

GlobeNewswire

7 months ago

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference
MLYS

GlobeNewswire

8 months ago

Mineralys Therapeutics to Participate in the Wells Fargo Healthcare Conference

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
MLYS

GlobeNewswire

8 months ago

Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024
MLYS

GlobeNewswire

8 months ago

Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024

Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,746 Shares
MLYS

GuruFocus.com

9 months ago

Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,746 Shares

Insider Sale at Mineralys Therapeutics Inc (MLYS): CFO and Secretary Adam Levy Sells Shares
MLYS

GuruFocus.com

9 months ago

Insider Sale at Mineralys Therapeutics Inc (MLYS): CFO and Secretary Adam Levy Sells Shares

MLYS

MT Newswires

9 months ago

HC Wainwright Initiates Mineralys Therapeutics at Buy Rating With $30 Price Target

Insider Sale: CEO Jon Congleton Sells Shares of Mineralys Therapeutics Inc (MLYS)
MLYS

GuruFocus.com

10 months ago

Insider Sale: CEO Jon Congleton Sells Shares of Mineralys Therapeutics Inc (MLYS)

MLYS

MT Newswires

10 months ago

Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing

Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares
MLYS

GuruFocus.com

10 months ago

Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
MLYS

GlobeNewswire

10 months ago

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors

Insider Sale: CFO and Secretary Adam Levy Sells 96,815 Shares of Mineralys Therapeutics Inc (MLYS)
MLYS

GuruFocus.com

10 months ago

Insider Sale: CFO and Secretary Adam Levy Sells 96,815 Shares of Mineralys Therapeutics Inc (MLYS)

MLYS

MT Newswires

10 months ago

Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
MLYS

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
MLYS

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
MLYS

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
MLYS

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
MLYS

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
MLYS

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
MLYS

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?
MLYS

Simply Wall St.

10 months ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
MLYS

Investor's Business Daily

10 months ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
MLYS

Business Wire

10 months ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
MLYS

Investor's Business Daily

10 months ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement
MLYS

GlobeNewswire

10 months ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
MLYS

GuruFocus.com

10 months ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways
MLYS

Yahoo Finance Video

10 months ago

How markets digested hot jobs print: Top takeaways

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"
MLYS

PR Newswire

10 months ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
MLYS

GlobeNewswire

10 months ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
MLYS

Insider Monkey

a year ago

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript

We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth
MLYS

Simply Wall St.

a year ago

We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024

Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks
MLYS

TipRanks

a year ago

Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript
MLYS

Insider Monkey

a year ago

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript

MLYS

GuruFocus.com

a year ago

Mineralys Therapeutics Inc (MLYS) Reports Increased R&D Expenses Amid Progress in ...

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024

Mineralys Therapeutics Announces $120 Million Private Placement Financing
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics Announces $120 Million Private Placement Financing

Editas Medicine to Participate in Upcoming Investor Conferences
MLYS

GlobeNewswire

a year ago

Editas Medicine to Participate in Upcoming Investor Conferences

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
MLYS

GlobeNewswire

a year ago

CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference
MLYS

GlobeNewswire

a year ago

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

Investors in ATN International (NASDAQ:ATNI) have unfortunately lost 45% over the last five years
MLYS

Simply Wall St.

a year ago

Investors in ATN International (NASDAQ:ATNI) have unfortunately lost 45% over the last five years

Covenant Logistics Group, Inc. (NASDAQ:CVLG) Q4 2023 Earnings Call Transcript
MLYS

Insider Monkey

a year ago

Covenant Logistics Group, Inc. (NASDAQ:CVLG) Q4 2023 Earnings Call Transcript

The Manitowoc Company, Inc. (MTW) Stock Declines While Market Improves: Some Information for Investors
MLYS

Zacks

a year ago

The Manitowoc Company, Inc. (MTW) Stock Declines While Market Improves: Some Information for Investors

Apparel and Footwear Retail Stocks Q3 Results: Benchmarking Dick's (NYSE:DKS)
MLYS

StockStory

a year ago

Apparel and Footwear Retail Stocks Q3 Results: Benchmarking Dick's (NYSE:DKS)

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates
MLYS

Zacks

a year ago

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools
MLYS

GlobeNewswire

a year ago

Ducommun, the Los Angeles Chargers and University of California, Irvine Mark Sixth Anniversary of STEM on the SidelinesTM Initiative Promoting Science, Technology, Engineering and Mathematics Among Southern California High Schools

MetroCity Bankshares (NASDAQ:MCBS) Is Increasing Its Dividend To $0.20
MLYS

Simply Wall St.

a year ago

MetroCity Bankshares (NASDAQ:MCBS) Is Increasing Its Dividend To $0.20

Here's Why We Think Metropolitan Bank Holding (NYSE:MCB) Is Well Worth Watching
MLYS

Simply Wall St.

a year ago

Here's Why We Think Metropolitan Bank Holding (NYSE:MCB) Is Well Worth Watching

MLYS

Thomson Reuters StreetEvents

a year ago

Q4 2023 Metropolitan Bank Holding Corp Earnings Call

Five Star Bancorp Declares Fourth Quarter 2023 Cash Dividend
MLYS

GlobeNewswire

a year ago

Five Star Bancorp Declares Fourth Quarter 2023 Cash Dividend

Olympic Steel Promotes Anthony G. Dominic to Vice President of Safety, Health and Environment
MLYS

Business Wire

a year ago

Olympic Steel Promotes Anthony G. Dominic to Vice President of Safety, Health and Environment

Q3 Earnings Roundup: Ross Stores (NASDAQ:ROST) And The Rest Of The Apparel and Footwear Retail Segment
MLYS

StockStory

a year ago

Q3 Earnings Roundup: Ross Stores (NASDAQ:ROST) And The Rest Of The Apparel and Footwear Retail Segment

Metropolitan Bank Holding Corp. (MCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
MLYS

Zacks

a year ago

Metropolitan Bank Holding Corp. (MCB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Basic Materials Roundup: Market Talk
MLYS

The Wall Street Journal

a year ago

Basic Materials Roundup: Market Talk

Mineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know
MLYS

Zacks

a year ago

Mineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know

10 Small-Cap Energy Stocks with Strong Returns
MLYS

Insider Monkey

a year ago

10 Small-Cap Energy Stocks with Strong Returns

Is Owens & Minor (OMI) Stock Undervalued Right Now?
MLYS

Zacks

a year ago

Is Owens & Minor (OMI) Stock Undervalued Right Now?

Newell (NWL) Poised for Growth, Unveils Strategic Realignment
MLYS

Zacks

a year ago

Newell (NWL) Poised for Growth, Unveils Strategic Realignment

Share on Social Networks: